Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carballo AM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carballo Amador, Manuel
Protein solubility plays an important role whether for biophysical and structural studies, or for production and delivery of therapeutic proteins. Poor solubility could lead to protein aggregation, which is an undesired physicochemical mechanism at a
Externí odkaz:
https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.764393
Autor:
Kerns SL; Departments of Radiation Oncology and Surgery, University of Rochester Medical Center, Rochester, NY., Fachal L; Department of Oncology., Dorling L; Department of Public Health and Primary Care., Barnett GC; Department of Public Health and Primary Care.; Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Baran A; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY., Peterson DR; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY., Hollenberg M; Department of Computational Biology, University of Rochester, Rochester, NY., Hao K; Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY., Narzo AD; Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY., Ahsen ME; Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY., Pandey G; Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY., Bentzen SM; Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, University of Maryland Greenebaum Cancer Center, School of Medicine, University of Maryland, Baltimore., Janelsins M; Departments of Radiation Oncology and Surgery, University of Rochester Medical Center, Rochester, NY., Elliott RM; Division of Cancer Sciences, the University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK., Pharoah PDP; Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Burnet NG; Division of Cancer Sciences, the University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK., Dearnaley DP; Academic Urooncology Unit, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Gulliford SL; Academic Urooncology Unit, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Aguado-Barrera ME; Fundación Pública Galega de Medicina Xenómica-Servizo Galego de Saude (SERGAS & Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Gómez-Caamaño A; Department of Radiation Oncology., Carballo AM; Department of Radiation Oncology., Peleteiro P; Department of Radiation Oncology., Lobato-Busto R; Department of Medical Physics., Stock R; Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain; Department of Radiation Oncology., Stone NN; Department of Urology., Ostrer H; Icahn School of Medicine at Mount Sinai, New York, NY; Departments of Pathology and Genetics, Albert Einstein College of Medicine, Bronx, NY., Usmani N; Division of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada., Singhal S, Tsuji H; National Institute of Radiological Science, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan., Imai T; National Institute of Radiological Science, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan., Saito S; Department of Pathology and Cell Biology, Columbia University, New York, NY.; Department of Urology, National Tokyo Medical Center, Tokyo, Japan., Eeles R; Division of Genetics and Epidemiology, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., DeRuyck K; Departments of Basic Medical Sciences and Radiotherapy, Ghent University Hospital, Ghent, Belgium., Parliament M; Division of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada., Dunning AM; Department of Public Health and Primary Care., Vega A; Fundación Pública Galega de Medicina Xenómica-Servizo Galego de Saude (SERGAS & Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela, Santiago de Compostela, Spain., Rosenstein BS; Departments of Radiation Oncology & Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY., West CML; Division of Cancer Sciences, the University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Feb 01; Vol. 112 (2), pp. 179-190.
Autor:
Kerns SL; Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Dorling L; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK., Fachal L; Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK; Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain., Bentzen S; Division of Biostatistics and Bioinformatics, University of Maryland Greenebaum Cancer Center, Baltimore, USA; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, USA., Pharoah PD; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK., Barnes DR; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK., Gómez-Caamaño A; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain., Carballo AM; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain., Dearnaley DP; Joint Department of Physics, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5NG, UK., Peleteiro P; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain., Gulliford SL; Joint Department of Physics, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5NG, UK., Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London SM2 5NG, UK., Michailidou K; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK., Carracedo Á; Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), 15706 Santiago de Compostela, Spain., Sia M; Department of Radiation Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, Canada., Stock R; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Stone NN; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sydes MR; Cancer and Other Non-Infectious Diseases, MRC Clinical Trials Unit, London WC2B 6NH, UK., Tyrer JP; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK., Ahmed S; Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK., Parliament M; Division of Radiation Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada., Ostrer H; Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA; Department of Genetics, Albert Einstein College of Medicine, Bronx, NY, USA., Rosenstein BS; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Radiation Oncology, New York University School of Medicine, New York, NY, USA., Vega A; Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain; Department of Radiation Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, Canada., Burnet NG; University of Cambridge, Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK., Dunning AM; Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK., Barnett GC; Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK; Department of Oncology, Box 193, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB0 0QQ, UK., West CM; Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester M20 4BX, UK. Electronic address: Catharine.West@manchester.ac.uk.
Publikováno v:
EBioMedicine [EBioMedicine] 2016 Aug; Vol. 10, pp. 150-63. Date of Electronic Publication: 2016 Jul 20.
Autor:
Fachal L; 1] Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain. [2] Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain., Gómez-Caamaño A; Department of Radiation Oncology, USC University Hospital Complex, SERGAS, Santiago de Compostela, Spain., Barnett GC; Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Peleteiro P; Department of Radiation Oncology, USC University Hospital Complex, SERGAS, Santiago de Compostela, Spain., Carballo AM; Department of Radiation Oncology, USC University Hospital Complex, SERGAS, Santiago de Compostela, Spain., Calvo-Crespo P; Department of Radiation Oncology, USC University Hospital Complex, SERGAS, Santiago de Compostela, Spain., Kerns SL; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sánchez-García M; Department of Medical Physics, USC University Hospital Complex, SERGAS, Santiago de Compostela, Spain., Lobato-Busto R; Department of Medical Physics, USC University Hospital Complex, SERGAS, Santiago de Compostela, Spain., Dorling L; Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Elliott RM; Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK., Dearnaley DP; Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, UK., Sydes MR; Cancer and Other Non-Infectious Diseases, Medical Research Council (MRC) Clinical Trials Unit, London, UK., Hall E; Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK., Burnet NG; Department of Oncology, University of Cambridge, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Carracedo Á; 1] Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain. [2] Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain. [3] Center of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University, Jeddah, Saudi Arabia., Rosenstein BS; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., West CM; Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK., Dunning AM; Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Vega A; 1] Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain. [2] Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
Publikováno v:
Nature genetics [Nat Genet] 2014 Aug; Vol. 46 (8), pp. 891-4. Date of Electronic Publication: 2014 Jun 29.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 Aug 20; Vol. 28 (24), pp. e416; author reply e417. Date of Electronic Publication: 2010 Jun 21.
Autor:
Carballo AM
Publikováno v:
Medicina [Medicina (B Aires)] 1987; Vol. 47 (1), pp. 109-10.